Changes in Senior Management Personnel ( SMP ) and Key Managerial Personnel ( KMP ) of the Company

Management Changes View source PDF Explain this filing

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹155.00

prior close

₹150.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-1.1% vs market

Pharmaceuticals peers, median of 158sector-0.6%-0.6% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.7

10m

+2.7

15m

+2.9

30m

+3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2-0.1-1.1-0.6-0.6

Next day

-0.2+0.8-1.0+0.7-0.9

+0.6-0.8+1.5-0.2+0.8

+3.9+2.1+1.9+2.4+1.5

+4.3+2.8+1.4+2.9+1.3

+2.4+1.8+0.6+2.2+0.2

+4.9+4.0+0.9+3.1+1.8

15d

+4.5+2.2+2.3+1.2+3.3

-1.3-0.4-0.9-2.0+0.7

-11.8-8.6-3.2-12.9+1.1

+3.6+7.4-3.9+3.3+0.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Piramal Pharma Limited has disclosed changes to its Senior Management Personnel and Key Managerial Personnel. The specific details regarding who has been appointed, resigned, or reassigned have not been provided in the headline. This is a routine corporate governance disclosure required under SEBI regulations whenever there is a change in top management roles such as CEO, CFO, CS, or other senior executives.

Likely market impact

Investors should look for the detailed filing to understand whether these changes involve resignations or new appointments, as senior management transitions can affect company strategy and execution. For now, the immediate impact is neutral pending further details.